SCHEMBL4048341

SCHEMBL4048341

COc1ccccc1Nc1nc(N(C(=O)OC(C)(C)C)C2CCNC2)nc(C(=O)O)c1[N+](=O)[O-]

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.40
TDP1 Q9NUW8 1/20 0.40
GSK3A P49840 2/20 0.39
GSK3B P49841 2/20 0.39
NR1I2 O75469 1/20 0.39
AHR P35869 1/20 0.39
CDK5 Q00535 1/20 0.39
CDK5R1 Q15078 1/20 0.39
KMT2A Q03164 6/20 0.37
MEN1 O00255 5/20 0.37
POLB P06746 2/20 0.37
RAD52 P43351 1/20 0.37
BLM P54132 1/20 0.37
ATM Q13315 1/20 0.37
ALDH1A1 P00352 4/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
GAA P10253 1/20 0.35
HTR2A P28223 1/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4048413 0.88 SLC6A2 (0.35) MAPTTDP1KMT2AMEN1POLB
SCHEMBL1749675 0.75 MAPT (0.39) MAPTTDP1GSK3AGSK3BNR1I2
SCHEMBL4050683 0.75 KDM4E (0.43) KMT2AMEN1ALDH1A1SMN1; SMN2GAA
SCHEMBL1749677 0.72 GSK3A (0.46) MAPTTDP1GSK3AGSK3BNR1I2
SCHEMBL1749679 0.72 GSK3A (0.46) MAPTTDP1GSK3AGSK3BNR1I2
SCHEMBL6121889 0.67 SLC6A3 (0.40) MAPTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL4436116 0.66 SLC6A4 (0.34) KMT2AMEN1CYP2D6SLC6A2SLC6A4
SCHEMBL28015927 0.65 GSK3A (0.41) MAPTTDP1GSK3AGSK3BNR1I2
SCHEMBL28015937 0.65 GSK3A (0.41) MAPTTDP1GSK3AGSK3BNR1I2
SCHEMBL28329578 0.64 SLC6A4 (0.39) CYP2D6SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078018-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS Signal Pharmaceuticals LLC (US) 2009-07-15 EP disclosed
WO-2008051494-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2008-05-02 WO disclosed